Related Experiment Video

Updated: Jun 16, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Epidemiological profile of meningococcal disease in the United States

Lee H Harrison1

  • 1University of Pittsburgh Graduate School of Public Health and School of Medicine, Pennsylvania, USA. lharriso@edc.pitt.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|February 11, 2010
PubMed

Insights

Neisseria meningitidis causes bacterial meningitis globally. New vaccines are needed, especially for serogroup B strains, to improve prevention of meningococcal disease.

Area of Science:

  • Microbiology
  • Epidemiology
  • Vaccinology

Background:

  • Neisseria meningitidis is a primary cause of bacterial meningitis and severe infections worldwide.
  • Meningococcal disease epidemiology varies significantly in incidence and serogroup distribution.
  • Serogroups A, B, C, W-135, X, and Y are responsible for the majority of global cases, each with a distinct disease profile.

Purpose of the Study:

  • To review the current landscape of meningococcal disease and available vaccines.
  • To identify gaps in current vaccination strategies and highlight the need for new vaccine development.

Main Methods:

  • Literature review of epidemiological data on Neisseria meningitidis.
  • Analysis of existing meningococcal vaccine profiles and recommendations.
  • Assessment of current challenges in meningococcal disease prevention.

Main Results:

  • No vaccine is currently available for endemic serogroup B meningococcal disease.
  • Licensed vaccines in the US include a tetravalent polysaccharide and a conjugate vaccine (A/C/Y/W-135).
  • Current conjugate vaccine recommendations for adolescents have low coverage, necessitating broader strategies.

Conclusions:

  • Infant vaccination is crucial for a comprehensive invasive meningococcal disease prevention program in the US.
  • Development of broadly protective vaccines for endemic serogroup B disease is urgently required.
  • Improved vaccine coverage and new vaccine formulations are essential to combat meningococcal disease globally.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature11:40

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...